126 related articles for article (PubMed ID: 5394570)
1. [Results with the new ovulation inhibitor Ovostat].
Lohmeyer H; Loch EG
Praxis; 1969 Oct; 58(40):1266-71. PubMed ID: 5394570
[No Abstract] [Full Text] [Related]
2. Ovanon. A new sequential oral contraceptive.
Rice-Wray E; Peña A; Maqueo M
Int J Fertil; 1968; 13(4):453-9. PubMed ID: 5700405
[No Abstract] [Full Text] [Related]
3. [Experience with a low dosage ovulation inhibitor].
Himmelsbach H
Med Monatsschr; 1969 Dec; 23(12):561-3. PubMed ID: 5387171
[TBL] [Abstract][Full Text] [Related]
4. [Ovostat, a low dose oral contraceptive].
Linthorst G; Wolff J
Brux Med; 1970 Jun; 50(6):433-7. PubMed ID: 5487467
[No Abstract] [Full Text] [Related]
5. [Clinical studies on Ovostat--a combined oral contraceptive with a low dose of lynestrenol].
Rice-Wray E; Cervantes A
Geburtshilfe Frauenheilkd; 1974 May; 34(5):380-3. PubMed ID: 4603404
[TBL] [Abstract][Full Text] [Related]
6. [Management of dysfunctional bleeding as well as hyper- and polymenorrheas using high doses of ovulation inhibitors].
Soergel W
Geburtshilfe Frauenheilkd; 1969 Feb; 29(2):159-65. PubMed ID: 5386827
[No Abstract] [Full Text] [Related]
7. [Trial of a new low-dose anti-ovulation contraceptive].
Bayot D
Schweiz Rundsch Med Prax; 1970 Apr; 59(16):593-7. PubMed ID: 5519719
[No Abstract] [Full Text] [Related]
8. [Ovanon (Nourypharma)--a normophasic ovulation inhibitor--field test].
Bayer R
Wien Klin Wochenschr; 1973 Apr; 85(15):241-4. PubMed ID: 4697116
[No Abstract] [Full Text] [Related]
9. Clinical evaluation of a normophasic oral contraceptive.
Notelovitz M
S Afr Med J; 1973 Oct; 47(41):1943-7. PubMed ID: 4748659
[No Abstract] [Full Text] [Related]
10. Inhibition of ovulation by estrogens.
Gual C; Becerra C; Rice-Wray E; Goldzieher JW
Am J Obstet Gynecol; 1967 Feb; 97(4):443-7. PubMed ID: 4163201
[No Abstract] [Full Text] [Related]
11. [The search for new ways with low dose contraceptives. II].
Tóth F; Gimes R; Horn B; Kerényi T
Z Arztl Fortbild (Jena); 1972 Oct; 66(20):1021-5. PubMed ID: 4651027
[No Abstract] [Full Text] [Related]
12. [Experiences with the 22-day use (so-called "Friday method") of oral progestagens for contraception].
Szontágh FE; Sas M
Zentralbl Gynakol; 1966 Oct; 88(43):1486-8. PubMed ID: 5995429
[No Abstract] [Full Text] [Related]
13. [Clinical study of a mestranol lynestrenol combination of 1 mg. (preliminary report)].
Mateos Cándano M; Bolio Arizta R
Ginecol Obstet Mex; 1969 Jun; 24(152):647-53. PubMed ID: 5800984
[No Abstract] [Full Text] [Related]
14. [Ovostat 22, a new oral contraceptive].
Himmelsbach H
Med Welt; 1974 Jan; 25(3):106-8. PubMed ID: 4840796
[No Abstract] [Full Text] [Related]
15. Oestrogen content of oral contraceptives and thromboembolism.
McQueen EG
N Z Med J; 1970 May; 71(456):317. PubMed ID: 5270982
[No Abstract] [Full Text] [Related]
16. [Clinical study of a mestranol lynestrenol combination of 1 mg. (preliminary report)].
Mateos Cándano M; Bolio Arizta R
Ginecol Obstet Mex; 1969 Jun; 25(152):647-53. PubMed ID: 5372809
[TBL] [Abstract][Full Text] [Related]
17. [Modification of the biphasic technic in hormonal contraception].
Rindt W
Med Welt; 1974 Jan; 25(4):153-5. PubMed ID: 4822930
[No Abstract] [Full Text] [Related]
18. [Evaluation of the efficacy and side effects of the contraceptive containing 0.5 mg of norethindrone and 0.1 mg of mestranol in a family planning clinic].
de Sampaio Júnior LF; Dib JE; Pereira VM; Neme B
Matern Infanc (Sao Paulo); 1971; 30(1):65-9. PubMed ID: 5135370
[No Abstract] [Full Text] [Related]
19. Low dose lynestrenol as a contraceptive influence on ovarian function.
Järvinen PA; Ylikorkala O; Ylöstalo P
Ann Clin Res; 1974 Apr; 6(2):109-14. PubMed ID: 4837883
[No Abstract] [Full Text] [Related]
20. [A new normophasic estro-progestational combination: fisioquens].
Cavrot E; Moulinasse R
Brux Med; 1974 Aug; 54(8):459-63. PubMed ID: 4425959
[No Abstract] [Full Text] [Related]
[Next] [New Search]
